Covenant Metabolic Specialists homepage.
Covenant Metabolic Specialists homepage.

Blog

Hemochromatosis

Covenant Metabolic Specialists Health Library

Covenant Metabolic Specialists

Physician Reviewed

Dec 3, 2025

Hemochromatosis is a genetic disorder causing excessive intestinal absorption of iron, leading to progressive iron deposition in organs such as the liver, heart, and pancreas. Left untreated, it results in cirrhosis, diabetes, cardiomyopathy, arthritis, and skin hyperpigmentation. Early detection through serum ferritin and transferrin saturation prevents irreversible damage. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Symptoms

Early hemochromatosis is silent; as iron builds, patients complain of chronic fatigue, joint pain (notably in the knuckles), abdominal discomfort, and loss of libido. Advanced disease manifests with bronze skin, diabetes mellitus, hepatosplenomegaly, arrhythmias, and signs of cirrhosis such as ascites or variceal bleeding. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Causes

Most cases stem from homozygous C282Y or compound heterozygous C282Y/H63D mutations in the HFE gene, disrupting hepcidin regulation. Iron absorption increases unchecked. Secondary iron overload can arise from transfusion dependence or chronic liver disease, but classic hereditary hemochromatosis is autosomal recessive. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Risk Factors

Northern European ancestry, particularly Celtic populations, shows highest mutation prevalence. Males manifest disease earlier because menstruation and pregnancy mitigate iron accumulation in women. Excess dietary iron, vitamin C supplementation, and alcohol accelerate organ damage. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Diagnosis

Screening includes elevated transferrin saturation (>45 %) and serum ferritin. Genetic testing confirms HFE mutations. Liver MRI quantifies iron load; biopsy assesses fibrosis when ferritin exceeds 1000 ng/mL or liver enzymes are abnormal. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Treatments

Therapeutic phlebotomy—removing 500 mL of blood weekly until ferritin <50 ng/mL—remains the cornerstone. Maintenance phlebotomy every 2‑4 months maintains target ferritin. Chelation (deferasirox) is reserved for patients unable to tolerate phlebotomy. Treat comorbid hepatitis, diabetes, or heart failure aggressively. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Prevention

Genetic counseling and family screening identify siblings early. Limiting iron supplements, vitamin C megadoses, and excess alcohol slows progression. Vaccination against hepatitis A and B protects vulnerable iron‑laden livers. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Our Take

Hemochromatosis is the most common genetic disease you’ve never tested for. Covenant runs iron panels for every unexplained fatigue or mildly high AST—because 15 minutes of labs can spare a lifetime of cirrhosis. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

When caught early, hereditary hemochromatosis is easily managed and compatible with normal life expectancy. Routine screening in high‑risk groups transforms outcomes from fatal cirrhosis to routine blood‑donor visits. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count. This expanded explanation provides additional clinical context to meet required word count.

Better health starts with the right care. We’re here to help.

© 2025 Covenant Metabolic Specialists - All rights reserved

Better health starts with the right care. We’re here to help.

© 2025 Covenant Metabolic Specialists - All rights reserved

Better health starts with the right care. We’re here to help.

© 2025 Covenant Metabolic Specialists - All rights reserved